Is losartan the drug for all seasons?

Francesco Ramirez is the Dr. Amy and James Elster Professor of Molecular Biology (Connective Tissue Diseases) in the Department of Pharmacology and Systems Therapeutics at the Mount Sinai School of Medicine in New York City. His long-standing research interest focuses on the role of ECM proteins in health and disease. Major accomplishments include the characterization of genetic lesions and pathophysiological mechanisms in osteogenesis imperfecta, Ehlers-Danlos syndrome, spondyloepiphyseal dysplasia, congenital contractural arachnodactyly and Marfan syndrome.

• Publication year

  2012

• Venue

  Current opinion in pharmacology (Print)

• Publication date

  2012-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.coph.2012.02.007PMID 22445547
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic Losartan Administration Reduces Mortality and Preserves Cardiac but Not Skeletal Muscle Function in Dystrophic Mice

  2011cited by this paper
• Losartan Restores Skeletal Muscle Remodeling and Protects Against Disuse Atrophy in Sarcopenia

  2011cited by this paper
• AT1 receptors as mechanosensors.

  2011cited by this paper
• Pharmacokinetic evaluation of losartan

  2011cited by this paper
• Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome.

  2010cited by this paper
• AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist

  2009cited by this paper
• Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.

  2008cited by this paper
• Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states

  2007cited by this paper
• Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome

  2006cited by this paper
• Angiotensin II Blockade Reverses Myocardial Fibrosis in a Transgenic Mouse Model of Human Hypertrophic Cardiomyopathy

  2001cited by this paper

• The Role of Myofibroblasts in Physiological and Pathological Tissue Repair.

  2022cites this paper
• Skin Fragility: Perspectives on Evidence-based Therapies

  2020cites this paper
• Newer Treatment Modalities in Epidermolysis Bullosa

  2019cites this paper
• The role of TGFβ in wound healing pathologies.

  2017cites this paper
• Chapter 22 – Antihypertensive Drugs

  2016cites this paper
• The role of myofibroblasts in wound healing.

  2016cites this paper
• Targeting the myofibroblast to improve wound healing

  2016cites this paper
• Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms

  2015influential citation